Search research articles
Contact Us
Filters
Showing results (471-480 of 594) with videos related to
Page
of 60
Sort By:
Breast Cancer Research and Treatment
|
June 12, 2016
Phase I biomarker modulation study of atorvastatin in women at increased risk for breast cancer
Banu K Arun, Yun Gong, Diane Liu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 11, 2020
Proteogenomic Analysis of Salivary Adenoid Cystic Carcinomas Defines Molecular Subtypes and Identifies Therapeutic Targets
Renata Ferrarotto, Yoshitsugu Mitani, Daniel J McGrail, et al.
Cancer Medicine
|
March 21, 2022
A WIN Consortium phase I study exploring avelumab, palbociclib, and axitinib in advanced non-small cell lung cancer
Benjamin Solomon, Ana Callejo, Jair Bar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 22, 2016
Activating NOTCH1 Mutations Define a Distinct Subgroup of Patients With Adenoid Cystic Carcinoma Who Have Poor Prognosis, Propensity to Bone and Liver Metastasis, and Potential Responsiveness to Notch1 Inhibitors
Renata Ferrarotto, Yoshitsugu Mitani, Lixia Diao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 3, 2018
Bayesian Adaptive Randomization Trial of Passive Scattering Proton Therapy and Intensity-Modulated Photon Radiotherapy for Locally Advanced Non-Small-Cell Lung Cancer
Zhongxing Liao, J Jack Lee, Ritsuko Komaki, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
February 20, 2019
PD-L1 Expression, Tumor Mutational Burden, and Cancer Gene Mutations Are Stronger Predictors of Benefit from Immune Checkpoint Blockade than HLA Class I Genotype in Non-Small Cell Lung Cancer
Marcelo V Negrao, Vincent K Lam, Alexandre Reuben, et al.
Cancer Prevention Research (Philadelphia, Pa.)
|
October 23, 2012
Characterizing the molecular spatial and temporal field of injury in early-stage smoker non-small cell lung cancer patients after definitive surgery by expression profiling
Humam Kadara, Li Shen, Junya Fujimoto, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 12, 2024
Proportional Hazards Violations in Phase III Cancer Clinical Trials: A Potential Source of Trial Misinterpretation
Timothy A Lin, Zachary R McCaw, Alex Koong, et al.
International Journal of Radiation Oncology, Biology, Physics
|
June 30, 2016
Intensity Modulated Proton Therapy Versus Intensity Modulated Photon Radiation Therapy for Oropharyngeal Cancer: First Comparative Results of Patient-Reported Outcomes
Terence T Sio, Huei-Kai Lin, Qiuling Shi, et al.
Advances in Radiation Oncology
|
March 18, 2021
The Reality of Randomized Controlled Trials for Assessing the Benefit of Proton Therapy: Critically Examining the Intent-to-Treat Principle in the Presence of Insurance Denial
Mike Hernandez, J Jack Lee, Beow Y Yeap, et al.
Page
of 60
Search research articles
Search
Showing results (471-480 of 594) with videos related to
Sort By:
Page
of 60
Breast Cancer Research and Treatment
|
June 12, 2016
Phase I biomarker modulation study of atorvastatin in women at increased risk for breast cancer
Banu K Arun, Yun Gong, Diane Liu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 11, 2020
Proteogenomic Analysis of Salivary Adenoid Cystic Carcinomas Defines Molecular Subtypes and Identifies Therapeutic Targets
Renata Ferrarotto, Yoshitsugu Mitani, Daniel J McGrail, et al.
Cancer Medicine
|
March 21, 2022
A WIN Consortium phase I study exploring avelumab, palbociclib, and axitinib in advanced non-small cell lung cancer
Benjamin Solomon, Ana Callejo, Jair Bar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 22, 2016
Activating NOTCH1 Mutations Define a Distinct Subgroup of Patients With Adenoid Cystic Carcinoma Who Have Poor Prognosis, Propensity to Bone and Liver Metastasis, and Potential Responsiveness to Notch1 Inhibitors
Renata Ferrarotto, Yoshitsugu Mitani, Lixia Diao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 3, 2018
Bayesian Adaptive Randomization Trial of Passive Scattering Proton Therapy and Intensity-Modulated Photon Radiotherapy for Locally Advanced Non-Small-Cell Lung Cancer
Zhongxing Liao, J Jack Lee, Ritsuko Komaki, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
February 20, 2019
PD-L1 Expression, Tumor Mutational Burden, and Cancer Gene Mutations Are Stronger Predictors of Benefit from Immune Checkpoint Blockade than HLA Class I Genotype in Non-Small Cell Lung Cancer
Marcelo V Negrao, Vincent K Lam, Alexandre Reuben, et al.
Cancer Prevention Research (Philadelphia, Pa.)
|
October 23, 2012
Characterizing the molecular spatial and temporal field of injury in early-stage smoker non-small cell lung cancer patients after definitive surgery by expression profiling
Humam Kadara, Li Shen, Junya Fujimoto, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 12, 2024
Proportional Hazards Violations in Phase III Cancer Clinical Trials: A Potential Source of Trial Misinterpretation
Timothy A Lin, Zachary R McCaw, Alex Koong, et al.
International Journal of Radiation Oncology, Biology, Physics
|
June 30, 2016
Intensity Modulated Proton Therapy Versus Intensity Modulated Photon Radiation Therapy for Oropharyngeal Cancer: First Comparative Results of Patient-Reported Outcomes
Terence T Sio, Huei-Kai Lin, Qiuling Shi, et al.
Advances in Radiation Oncology
|
March 18, 2021
The Reality of Randomized Controlled Trials for Assessing the Benefit of Proton Therapy: Critically Examining the Intent-to-Treat Principle in the Presence of Insurance Denial
Mike Hernandez, J Jack Lee, Beow Y Yeap, et al.
Page
of 60